Andreas Josting - Concepedia

Author

Andreas Josting

University Hospital Cologne

Also Known As

A Josting, A. Josting, Andreas Josting, Josting A.

124

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

University Hospital Cologne University of Cologne German Inflammatory Bowel Diseases Study Group Ludwig-Maximilians-Universität München Carl-Thiem-Klinikum Cottbus

About

Andreas Josting is an author at University Hospital Cologne specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	28	1.9K
2	Health Sciences	6	6	257
3	Cellular Therapies	5	5	252
4	Public Health	3	3	473
5	Blood Transplantation	1	1	37

Andreas Josting

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group Andreas Engert, Petra Schiller, Andreas Josting, Journal of Clinical Oncology	2003	456
New Prognostic Score Based on Treatment Outcome of Patients With Relapsed Hodgkin's Lymphoma Registered in the Database of the German Hodgkin's Lymphoma Study Group Andreas Josting Journal of Clinical Oncology	2002	272
Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease Andreas Josting, Christian Rudolph, Marcel Reiser, Annals of Oncology Refractory Hodgkin ’Lymphoid NeoplasiaLow ToxicityClinical TherapeuticMedicine	2002	219
Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial Thomas Elter, Peter Borchmann, H. Schulz, Journal of Clinical Oncology	2005	212
Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group Andreas Josting, U. Rueffer, Jeremy Franklin, Blood	2000	207
Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment U. Rueffer, Kai Breuer, Andreas Josting, Annals of Oncology InfertilityUrologyAndrologyFertilityGonadotropin Biology	2001	202
Hodgkin's Lymphoma in Elderly Patients: A Comprehensive Retrospective Analysis From the German Hodgkin's Study Group Andreas Engert, Veronika Ballová, Heinz Haverkamp, Journal of Clinical Oncology	2005	189
Improvement in the outcome of invasive fusariosis in the last decade Márcio Nucci, Kieren A. Marr, Maria J. G. T. Vehreschild, Clinical Microbiology and Infection Diagnostic MycologyFungal PathogenPathologyPlant PathologyInvasive Fusariosis	2013	187
Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma Andreas Josting, Horst Müller, Peter Borchmann, Journal of Clinical Oncology	2010	160
Secondary Myeloid Leukemia and Myelodysplastic Syndromes in Patients Treated for Hodgkin’s Disease: A Report From the German Hodgkin’s Lymphoma Study Group Andreas Josting, S. Wiedenmann, Jeremy Franklin, Journal of Clinical Oncology	2003	159

Page 1